Business Standard
Saturday, Feb 18, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Ranbaxy, Aurobindo get USFDA nod for migraine drug
BS Reporter / Mumbai Aug 11, 2009, 15:17 IST

Pharma majors Ranbaxy and Aurobindo Pharma today said that they have received final approval from the US Food and Drug Administration(USFDA) to manufacture and market Sumatripan Succinate.

While Ranbaxy got approval for 25 and 50 mg varients of the drug, Aurobindo got the approval for 100 mg tablets apart from 25 and 50 mg tablets.

The Office of Generic Drugs, USFDA, has determined the Ranbaxy formulations to be bio-equivalent and have the same therapeutic effect that of the reference listed drug Imitrex manufactured by GlaxoSmithkilne.

The drug is used in the treatment of migraine in adults. Ranbaxy shares were trading at Rs 275.25, nearly 14.25 per cent higher than Monday's close. Aurobindo stock was trading at Rs 615.05, nearly 3.35 per cent down from Monday's close.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Wall Street up on Greece, but gains seen limited
- FII-TO-FII: Pantaloon traded at 7% premium
- Civic polls: Saffron alliance retains Mumbai, Thane
- MCX awaits trading rules in commodity options, indices
- Govt to provide incentives for electronic chip manufacturing
  Read Business news in 
- Now property search gets more exciting than ever before!
- High Growth Business Opportunities in Africa - Register to explore
- Medium-sized businesses are the engines of a smarter planet.
- Save over Rs.3000 with IndianOil Citibank Card
- India's No. 1 Property Site. Click here to know more..
- Get 5% cashback on telephone bills with Citi
- Diseases earlier, Saving Costs, Extending Lives. Know More..
- Enjoy the journey as much as the destination. click to know more..
- Exim Bank Conclave on India - Africa Project Partnership. Know more..
- Creating Wealth made simple the SIP way. Know more..
- Only Developer to give a guarantee on time space & rate.
- Office 365 for professionals and small businesses.
- Buy Your Property with Our Triple Guarantee in India.
- Improve Patient Care & Experience. Click here to know more
- Win a Business Class Ticket to Europe..Know more..
-  Introduce a New Automotive Luxury Car.. know more
Sorry, comments to this story are closed
Latest Messages
SmartInvestor+ E-zine
  Pay Rs.747/- for 3 years and
  get a branded watch FREE

  Subscribe Now
Most Popular
Read
E-Mailed
Commented
   
- T N Ninan: Saving Mumbai
- The malt of India
- Lehman withdraws winding-up petition against Wockhardt
- The painter of a dream world
- Ways of seeing
 
 More  
BUSINESS STANDARD INDIA 2012
  Now available at Special price
  Rs.395/- Only
  Buy Now
  Now available on the Kindle Store...
  BS Specials  
    Full coverage of elections in Uttar Pradesh, Punjab, Uttarakhand, Manipur and Goa
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
FOR HOT PRODUCTS
BS Bazaar.com
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us